ACADIA Pharmaceuticals (NASDAQ:ACAD) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
ACADIA Pharmaceuticals their estimated earnings by 65.38%, reporting an EPS of $-0.09 versus an estimate of $-0.26, which surprised analysts.
Revenue was up $11,035,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04, which was followed by a 8.55% drop in the share price the next day.
Here’s a look at ACADIA Pharmaceuticals’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.53 | -0.47 | -0.38 |
| EPS Actual | -0.27 | -0.42 | -0.42 | -0.54 |
| Revenue Estimate | 126.15M | 111.63M | 123.20M | 118.82M |
| Revenue Actual | 115.22M | 106.55M | 121.01M | 120.58M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
